Skip to content

Author

Tsutomu Fujii

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): A Prospective, Single-Arm, Phase II Study.

It is suggested that GnP-based CRT showed encouraging clinical activity with manageable toxicity in patients with LAPC, and future studies are needed to validate the additional benefits of radiotherapy.

Hironori Yamada, H. Tanaka, S. Yamada et al. · 0 citations
Aug 2026

P1.035. Postoperative Acid-Suppressive Therapy Duration and Risk Factor of Gastroesophageal Reflux Disease Following Subtotal Esophagectomy

Continuation of acid-suppressive therapy for at least one year after esophagectomy may help reduce the incidence of postoperative GERD, and the optimal duration of acid-suppressive therapy after esophagectomy remains unclear and requires further investigation.

Yoshihisa Numata, Tomoyuki Okumura, T. Miwa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.